Patents by Inventor John M. Baldoni

John M. Baldoni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electrospun pharmaceutical compositions
    Publication number: 20030017208
    Abstract: The present invention is directed to an electrospun pharmaceutical composition comprising a pharmaceutically acceptable actibe agent, and a pharmaceutically acceptable polymeric carrier for use in therapy.
    Type: Application
    Filed: July 19, 2002
    Publication date: January 23, 2003
    Inventors: Francis Ignatious, John M. Baldoni
  • Crystalline amifostine compositions
    Patent number: 5591731
    Abstract: The present invention relates to a sterile, stable vacuum dried crystalline amifostine composition and, optionally, pharmaceutically acceptable excipient(s). Typically, the crystalline compositions of the present invention exhibit enhanced stability at temperatures ranging from about 4.degree. C. to about ambient temperature for a period of at least 2 years relative to existing solid vacuum dried amorphous amifostine preparations. The reconstituted compositions of the present invention are suitable for administration to humans as a radio- or chemoprotecting agent.
    Type: Grant
    Filed: February 16, 1995
    Date of Patent: January 7, 1997
    Assignee: U.S. Bioscience, Inc.
    Inventors: Paul E. Kennedy, Roger A. Rajewski, John M. Baldoni
  • Crystalline amifostine compositions and methods of the preparation and use of same
    Patent number: 5424471
    Abstract: The present invention relates to a sterile, stable vacuum dried crystalline amifostine composition and, optionally, pharmaceutically acceptable excipient(s). Typically, the crystalline compositions of the present invention exhibit enhanced stability at temperatures ranging from about 4.degree. C. to about ambient temperature for a period of at least 2 years relative to existing solid vacuum dried amorphous amifostine preparations. The reconstituted compositions of the present invention are suitable for administration to humans as a radio- or chemoprotecting agent.
    Type: Grant
    Filed: July 29, 1993
    Date of Patent: June 13, 1995
    Assignee: U.S. Bioscience, Inc.
    Inventors: Paul E. Kennedy, Roger A. Rajewski, John M. Baldoni
  • Aluminum complex of polysulfonated sucrose
    Patent number: 5084446
    Abstract: A sucralfate-like chemical compound which is free flowing but turns viscid upon contact with acid or non-acid aqueous liquid. The compound is prepared by adding an excess of aluminum chlorohydrate to sucrose octaammonium sulfate in aqueous alcohols.
    Type: Grant
    Filed: July 19, 1989
    Date of Patent: January 28, 1992
    Assignee: Applied Analytical Industries, Inc.
    Inventors: John M. Baldoni, Nick V. Lazaridis